Study lead author Opeolu Adeoye, M.D., M.S., FAHA, is an American Heart/Stroke Association volunteer and chair of the Department of Emergency Medicine at Washington University School of Medicine in St. Louis.
Study lead author Opeolu Adeoye, M.D., M.S., FAHA, is an American Heart/Stroke Association volunteer and chair of the Department of Emergency Medicine at Washington University School of Medicine in St. Louis.
Study lead author Opeolu Adeoye, M.D., M.S., FAHA, is an American Heart/Stroke Association volunteer and chair of the Department of Emergency Medicine at Washington University School of Medicine in St. Louis.
Study lead author Opeolu Adeoye, M.D., M.S., FAHA, is an American Heart/Stroke Association volunteer and chair of the Department of Emergency Medicine at Washington University School of Medicine in St. Louis.
Dr. Feng ISC25 LB16 Brain stimulation demonstration
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Feng ISC25 LB16 comparing CIMT and Brain stimulation
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Feng ISC25 LB16 suprised by TRANSPORT 2 results
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Study principal investigator, Wayne Feng, M.D., M.S., professor of neurology and biomedical engineering at Duke University School of Medicine in Durham, North Carolina discusses the TRANSPORT 2 Trial (LB16) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Urs Fischer, M.D. M.Sc., co-principal investigator of the DISTAL trial and director of neurology at the University Hospital Bern in Switzerland discusses the trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Fischer - ISC25 LB3 - New treatment options needed
Urs Fischer, M.D. M.Sc., co-principal investigator of the DISTAL trial and director of neurology at the University Hospital Bern in Switzerland discusses the trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Fischer - ISC25 LB3 - thanks to patients-families and more
Urs Fischer, M.D. M.Sc., co-principal investigator of the DISTAL trial and director of neurology at the University Hospital Bern in Switzerland discusses the trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Fischer ISC LB3 stroke treatment options defined
Urs Fischer, M.D. M.Sc., co-principal investigator of the DISTAL trial and director of neurology at the University Hospital Bern in Switzerland discusses the trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Fullerton ISC25-TMP90 limitations and importance
AHA volunteer expert: Heather J. Fullerton, M.D., M.A.S., is co-chair of the American Heart Association 2019 Scientific Statement Management of Stroke in Neonates and Children and professor of Neurology & Pediatrics; Kenneth Rainin Chair of Pediatric Stroke Care; chief, Division of Child Neurology and medical director at the Pediatric Brain Center at UCSF Benioff Children’s Hospitals in San Francisco, California.
Dr. Fullerton ISC25-TMP90 pediatric stroke consequences
AHA volunteer expert: Heather J. Fullerton, M.D., M.A.S., is co-chair of the American Heart Association 2019 Scientific Statement Management of Stroke in Neonates and Children and professor of Neurology & Pediatrics; Kenneth Rainin Chair of Pediatric Stroke Care; chief, Division of Child Neurology and medical director at the Pediatric Brain Center at UCSF Benioff Children’s Hospitals in San Francisco, California.
AHA volunteer expert: Heather J. Fullerton, M.D., M.A.S., is co-chair of the American Heart Association 2019 Scientific Statement Management of Stroke in Neonates and Children and professor of Neurology & Pediatrics; Kenneth Rainin Chair of Pediatric Stroke Care; chief, Division of Child Neurology and medical director at the Pediatric Brain Center at UCSF Benioff Children’s Hospitals in San Francisco, California.
Dr. Fullerton ISC25-TMP90 stroke and mental health
AHA volunteer expert: Heather J. Fullerton, M.D., M.A.S., is co-chair of the American Heart Association 2019 Scientific Statement Management of Stroke in Neonates and Children and professor of Neurology & Pediatrics; Kenneth Rainin Chair of Pediatric Stroke Care; chief, Division of Child Neurology and medical director at the Pediatric Brain Center at UCSF Benioff Children’s Hospitals in San Francisco, California.
Dr. Fullerton ISC25-TMP90 under recognized problem
AHA volunteer expert: Heather J. Fullerton, M.D., M.A.S., is co-chair of the American Heart Association 2019 Scientific Statement Management of Stroke in Neonates and Children and professor of Neurology & Pediatrics; Kenneth Rainin Chair of Pediatric Stroke Care; chief, Division of Child Neurology and medical director at the Pediatric Brain Center at UCSF Benioff Children’s Hospitals in San Francisco, California.
Dr. Fullerton ISC25-TMP90 understanding pediatric stroke
AHA volunteer expert: Heather J. Fullerton, M.D., M.A.S., is co-chair of the American Heart Association 2019 Scientific Statement Management of Stroke in Neonates and Children and professor of Neurology & Pediatrics; Kenneth Rainin Chair of Pediatric Stroke Care; chief, Division of Child Neurology and medical director at the Pediatric Brain Center at UCSF Benioff Children’s Hospitals in San Francisco, California.
AHA volunteer expert: Philip B. Gorelick, M.D., M.P.H., FAHA, is immediate past chair of the American Heart Association’s Stroke Brain Health Science Subcommittee and professor of neurology in the Ken & Ruth Davee Department of Neurology at Northwestern University’s Feinberg School of Medicine in Chicago.
AHA volunteer expert: Philip B. Gorelick, M.D., M.P.H., FAHA, is immediate past chair of the American Heart Association’s Stroke Brain Health Science Subcommittee and professor of neurology in the Ken & Ruth Davee Department of Neurology at Northwestern University’s Feinberg School of Medicine in Chicago.
AHA volunteer expert: Philip B. Gorelick, M.D., M.P.H., FAHA, is immediate past chair of the American Heart Association’s Stroke Brain Health Science Subcommittee and professor of neurology in the Ken & Ruth Davee Department of Neurology at Northwestern University’s Feinberg School of Medicine in Chicago.
Dr. Gorelick ISC25-100 Med. Diet and brain structure
AHA volunteer expert: Philip B. Gorelick, M.D., M.P.H., FAHA, is immediate past chair of the American Heart Association’s Stroke Brain Health Science Subcommittee and professor of neurology in the Ken & Ruth Davee Department of Neurology at Northwestern University’s Feinberg School of Medicine in Chicago.
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Huo ISC25 LB38 defines success in ANGEL-TNK trial
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Xiaochuan Huo, M.D., Ph.D., lead author of the study and director of the neurological disease center at Beijing Anzhen Hospital in China, discusses the ANGEL-TNK (LB38) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Iadecola ISC25-DP3 brain aging study implications
AHA volunteer expert: Costantino Iadecola, M.D., FAHA, is the director and chair of the Feil Family Brain and Mind Research Institute and Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, New York.
AHA volunteer expert: Costantino Iadecola, M.D., FAHA, is the director and chair of the Feil Family Brain and Mind Research Institute and Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, New York.
AHA volunteer expert: Costantino Iadecola, M.D., FAHA, is the director and chair of the Feil Family Brain and Mind Research Institute and Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, New York.
AHA volunteer expert: Costantino Iadecola, M.D., FAHA, is the director and chair of the Feil Family Brain and Mind Research Institute and Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, New York.
Dr. Iadecola ISC25-DP3 lifestyle impact on brain aging
AHA volunteer expert: Costantino Iadecola, M.D., FAHA, is the director and chair of the Feil Family Brain and Mind Research Institute and Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, New York.
AHA volunteer expert: Costantino Iadecola, M.D., FAHA, is the director and chair of the Feil Family Brain and Mind Research Institute and Anne Parrish Titzell Professor of Neurology at Weill Cornell Medicine, New York.
Dr. Lackland ISC25-19 dental flossing and CVD risk
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Dr. Lackland ISC25-19 healthy habits to lower CVD risk
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Lou ISC25 LB41 what's different about this study
Principal investigator, Min Lou, M.D., Ph.D., a professor at the Second Affiliated Hospital of Zhejiang University’s School of Medicine in China, discusses the HOPE Trial (LB41) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
AHA volunteer expert: Tracy E. Madsen, M.D., Ph.D., is chair of the American Heart Association Clinical Cardiology (CLCD)/Stroke Women’s Health Science Committee and associate professor of emergency medicine at The Robert Larner, M.D. College of Medicine at The University of Vermont.
AHA volunteer expert: Tracy E. Madsen, M.D., Ph.D., is chair of the American Heart Association Clinical Cardiology (CLCD)/Stroke Women’s Health Science Committee and associate professor of emergency medicine at The Robert Larner, M.D. College of Medicine at The University of Vermont.
AHA volunteer expert: Tracy E. Madsen, M.D., Ph.D., is chair of the American Heart Association Clinical Cardiology (CLCD)/Stroke Women’s Health Science Committee and associate professor of emergency medicine at The Robert Larner, M.D. College of Medicine at The University of Vermont.
AHA volunteer expert: Tracy E. Madsen, M.D., Ph.D., is chair of the American Heart Association Clinical Cardiology (CLCD)/Stroke Women’s Health Science Committee and associate professor of emergency medicine at The Robert Larner, M.D. College of Medicine at The University of Vermont.
Dr. Madsen ISC25-TMP22 Propranolol and stroke risk
AHA volunteer expert: Tracy E. Madsen, M.D., Ph.D., is chair of the American Heart Association Clinical Cardiology (CLCD)/Stroke Women’s Health Science Committee and associate professor of emergency medicine at The Robert Larner, M.D. College of Medicine at The University of Vermont.
AHA volunteer expert: Tracy E. Madsen, M.D., Ph.D., is chair of the American Heart Association Clinical Cardiology (CLCD)/Stroke Women’s Health Science Committee and associate professor of emergency medicine at The Robert Larner, M.D. College of Medicine at The University of Vermont.
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
Dr. McCullough ISC25-106 oral health-chronic inflammation
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
Dr. McCullough ISC25-106 study limitations-next steps
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
Dr. McCullough ISC25-47 diagnosing stroke is critical
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
Dr. McCullough ISC25-47 GFAP and treatment decisions
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
Dr. McCullough ISC25-47 interesting-surprising results
AHA volunteer expert: Louise D. McCullough, M.D., P.H.D., FAHA, is the Roy M. and Phyllis Gough Huffington Distinguished Chair of Neurology at McGovern Medical School; chief of neurology at Memorial Hermann Hospital-Texas Medical Center and co-director of UTHealth Neurosciences, all in Houston.
Dr. Psychogios - ISC25 LB3 - collaborative effort and thank yous
Lead study author Marios Psychogios, M.D. head of diagnostic and interventional neuroradiology at the University Hospital Basel in Switzerland. discusses the DISTAL Trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Psychogios - ISC25 LB3 - DISTAL Trial findings
Lead study author Marios Psychogios, M.D. head of diagnostic and interventional neuroradiology at the University Hospital Basel in Switzerland. discusses the DISTAL Trial (LB 3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
Dr. Psychogios - ISC25 LB3 - QOL stroke treatments next steps
Lead study author Marios Psychogios, M.D. head of diagnostic and interventional neuroradiology at the University Hospital Basel in Switzerland. discusses the DISTAL Trial (LB3) being presented at the International Stroke Conference Feb. 5-7 in Los Angeles.
AHA volunteer expert: Preeti Raghavan, M.D., is chair of the American Stroke Association Rehab and Recovery committee and associate professor of physical medicine and rehabilitation in the Johns Hopkins Department of Physical Medicine and Rehabilitation.
Dr. Raghavan ISC25-22 moving toward implementation
AHA volunteer expert: Preeti Raghavan, M.D., is chair of the American Stroke Association Rehab and Recovery committee and associate professor of physical medicine and rehabilitation in the Johns Hopkins Department of Physical Medicine and Rehabilitation.
AHA volunteer expert: Preeti Raghavan, M.D., is chair of the American Stroke Association Rehab and Recovery committee and associate professor of physical medicine and rehabilitation in the Johns Hopkins Department of Physical Medicine and Rehabilitation.
AHA volunteer expert: Preeti Raghavan, M.D., is chair of the American Stroke Association Rehab and Recovery committee and associate professor of physical medicine and rehabilitation in the Johns Hopkins Department of Physical Medicine and Rehabilitation.
AHA volunteer expert: Preeti Raghavan, M.D., is chair of the American Stroke Association Rehab and Recovery committee and associate professor of physical medicine and rehabilitation in the Johns Hopkins Department of Physical Medicine and Rehabilitation.
Dr. Testai ISC25-WMP15 biological age vs. chron. age
AHA volunteer expert: Fernando D. Testai, M.D., Ph.D., FAHA, is chair of the October 2024 American Heart Association scientific statement Cardiac Contributions to Brain Health and professor of neurology and rehabilitation at the University of Illinois College of Medicine in Chicago.
AHA volunteer expert: Fernando D. Testai, M.D., Ph.D., FAHA, is chair of the October 2024 American Heart Association scientific statement Cardiac Contributions to Brain Health and professor of neurology and rehabilitation at the University of Illinois College of Medicine in Chicago.
AHA volunteer expert: Fernando D. Testai, M.D., Ph.D., FAHA, is chair of the October 2024 American Heart Association scientific statement Cardiac Contributions to Brain Health and professor of neurology and rehabilitation at the University of Illinois College of Medicine in Chicago.
AHA volunteer expert: Fernando D. Testai, M.D., Ph.D., FAHA, is chair of the October 2024 American Heart Association scientific statement Cardiac Contributions to Brain Health and professor of neurology and rehabilitation at the University of Illinois College of Medicine in Chicago.
Dr. Testai ISC25-WMP15 provides additional cognition data
AHA volunteer expert: Fernando D. Testai, M.D., Ph.D., FAHA, is chair of the October 2024 American Heart Association scientific statement Cardiac Contributions to Brain Health and professor of neurology and rehabilitation at the University of Illinois College of Medicine in Chicago.
Dr. Testai ISC25-WMP15 what AI-ECG data may teach us
AHA volunteer expert: Fernando D. Testai, M.D., Ph.D., FAHA, is chair of the October 2024 American Heart Association scientific statement Cardiac Contributions to Brain Health and professor of neurology and rehabilitation at the University of Illinois College of Medicine in Chicago.
ISC25 Chair, Lauren Sansing, MD, MS, FAHA, Yale University, New Haven, CT and ISC25 Vice-Chair, Bijoy Menon, MBBS, MD, Msc, FRCPC, University of Calgary, Calgary, AB, Canada discuss highlights from the American Stroke Association's International Stroke Conference 2025, Feb. 5-7, 2025 at the Los Angeles Convention Center.
